CSIMarket Company Name, Ticker, Industry, else..
 

Metavia Inc   (NASDAQ: MTVA)

Metavia Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

MTVA Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, Metavia Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 22.79 %, recorded in the same quarter.

• List of MTVA Competitors





Revenue Growth Comparisons




Net Income Comparison

Metavia Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  MTVA Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Metavia Inc




Acadia Pharmaceuticals Inc
Share Performance



-9.67%
30 Days
Acadia Pharmaceuticals Inc
Profile

Acadia Pharmaceuticals Inc's business model centers around the research, development, and commercialization of innovative medicines for diseases related to the central nervous system. They collaborate with a network of partners and employ a combination of in-house research and licensing agreements to discover and develop drug candidates. Their primary revenue stream comes from the sales of approved products, with a focus on providing effective therapeutic options for patients with unmet medical needs.

More about Acadia Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,717.104 mill. $ 1,138.643 mill. $ 380.484 mill.


Gossamer Bio Inc
Share Performance



0.00%
Over The Past 5 Days
Gossamer Bio Inc
Profile

Gossamer Bio Inc operates with a business model focused on the development and commercialization of novel therapies for patients with complex diseases. They leverage extensive scientific expertise and strategic partnerships to identify and advance a diverse pipeline of innovative medicines. Their goal is to deliver transformative therapies that address significant unmet medical needs and improve patient outcomes.

More about Gossamer Bio Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 44.097 mill. $ 53.286 mill. $ -123.445 mill.


Gain Therapeutics inc
Share Performance



+0.57%
Over The Past 5 Days
Gain Therapeutics inc
Profile

Gain Therapeutics inc's business model revolves around using cutting-edge technology and innovative approaches to identify and develop small molecules that can effectively target and treat rare genetic diseases, such as lysosomal storage disorders and CNS-related disorders. They aim to leverage their expertise in computational drug design and protein structure analysis to discover potential drug candidates, which can then be developed and commercialized for therapeutic purposes.

More about Gain Therapeutics inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 75.468 mill. $ - mill. $ -20.106 mill.


Filana Therapeutics Inc
Share Performance



-40.16%
This Quarter
Filana Therapeutics Inc
Profile

Filana Therapeutics develops simufilam, a treatment for TSC-related epilepsy that targets filamin A.

More about Filana Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 35.265 mill. $ - mill. $ -77.901 mill.


Crinetics Pharmaceuticals Inc
Share Performance



+1.42%
30 Days
Crinetics Pharmaceuticals Inc
Profile

Crinetics Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. They primarily generate revenue through the sale of their developed drugs and potential partnerships with other pharmaceutical companies.

More about Crinetics Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 8,967.322 mill. $ 42.156 mill. $ -501.606 mill.

20 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Metavia Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Metavia Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.